Related references
Note: Only part of the references are listed.DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer
Jacqulyne P. Robichaux et al.
NATURE MEDICINE (2018)
Prognostic Factors for the Survival Outcome of Bilateral Thalamic Glioma: An Integrated Survival Analysis
Xiaodong Niu et al.
WORLD NEUROSURGERY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Altered conformational landscape and dimerization dependency underpins the activation of EGFR by αC-β4 loop insertion mutations
Zheng Ruan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts
Alberto Broniscer et al.
BRAIN PATHOLOGY (2018)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
Pediatric thalamic tumors in the MRI era: a Canadian perspective
Paul Steinbok et al.
CHILDS NERVOUS SYSTEM (2016)
Neuropsychological Deterioration Predicts Tumor Progression in a Young Boy With Bithalamic Glioma
Laura Peruzzi et al.
APPLIED NEUROPSYCHOLOGY-CHILD (2016)
EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy
Jason Y. Park et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer
Toshiyuki Hirano et al.
ONCOTARGET (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
David A. Nathanson et al.
SCIENCE (2014)
Pediatric bilateral large concurrent thalamic glioblastoma: An unusual case report
Nityanand Pandey et al.
JOURNAL OF PEDIATRIC NEUROSCIENCES (2014)
Functional normalization of 450k methylation array data improves replication in large cancer studies
Jean-Philippe Fortin et al.
GENOME BIOLOGY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Bilateral Thalamic Lesions in a Child
Puneet Jain et al.
EUROPEAN NEUROLOGY (2013)
Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions
Geoffrey R. Oxnard et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
Maria E. Arcila et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Low-level processing of Illumina Infinium DNA Methylation BeadArrays
Timothy J. Triche et al.
NUCLEIC ACIDS RESEARCH (2013)
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
Hiroyuki Yasuda et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
David Akhavan et al.
CANCER DISCOVERY (2013)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Differential Sensitivity of Glioma-versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors
Igor Vivanco et al.
CANCER DISCOVERY (2012)
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
David M. Peereboom et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Bilateral thalamic glioma in a 6-year-old child
Dinesh K. Rajput et al.
JOURNAL OF PEDIATRIC NEUROSCIENCES (2010)
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Michael D. Prados et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N. Sarkaria et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain
Jeffrey C. Lee et al.
PLOS MEDICINE (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Diagnostic difficulties in childhood bilateral thalamic astrocytomas
S Gudowius et al.
NEUROPEDIATRICS (2002)
Multimodal target point assessment for stereotactic biopsy with diffuse bithalamic in children astrocytomas
AM Messing-Jünger et al.
CHILDS NERVOUS SYSTEM (2002)
Bilateral thalamic tumors in children
C Di Rocco et al.
CHILDS NERVOUS SYSTEM (2002)
Share Paper
